STE Stock: STERIS plc Stock Price, Analysis & Insights
Get live ste stock price $260.06, comprehensive STERIS plc stock analysis, charts, news, and expert forecast. Real-time ste stock data and investment insights.
Loading chart...
Company Overview
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Company Information
- CEO
- Daniel A. Carestio
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 18000
Contact Information
- Website
- https://www.steris.com
- Address
- 70 Sir John Rogerson's Quay
- Country
- IE
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 37.3)
Business Model & Strategy
STERIS plc operates in the Medical - Devices industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Daniel A. Carestio, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Devices model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
STERIS plc competes in the Medical - Devices within the broader Healthcare. With 25.6 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, STERIS plc provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating STERIS plc should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for STERIS plc shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for STERIS plc
- ⚠Investors should consider how STERIS plc fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 37.3) requires strong growth to justify
Market Cap
25.61B
P/E Ratio
37.31
Beta
1.03
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 25.61B market capitalization
- Trading Volume: 1.61M shares traded today
- Price Range: 52-week range of $200.98 - $265.56
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for STERIS plc
STERIS plc (STE) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 25.61B, the company represents a significant player in its market. The stock is currently trading at $260.06 with a positivedaily change of 6.94%.
The company's 18000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 37.31, beta of 1.03, and 52-week price range from $200.98 to $265.56when evaluating investment opportunities.
Why Invest in STERIS plc?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Daniel A. Carestio
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.